Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03403257 · ClinicalTrials.gov registry record
Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
A clinical trial of Dementia and Dementia, Vascular, sponsored by University of Michigan.
- Active
- Registry status
- 634
- Enrollment target
- 1
- Study location
NCT03403257: Active study of Dementia and Dementia, Vascular, sponsored by University of Michigan.
NCT03403257 is a study of Dementia and Dementia, Vascular that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 634 participants, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03403257, a study of Dementia and Dementia, Vascular, is active but no longer recruiting, sponsored by University of Michigan.
- ACTIVE NOT RECRUITING
- Registry status
- 634 participants
- Enrollment target
- 1
- Study location
Study Summary
The Mexican American population in the U.S. is rapidly growing and aging. This project seeks to determine the prevalence and outcomes of cognitive impairment and dementia in Mexican Americans. It also seeks solutions to help patients with cognitive impairment and dementia and their caregivers get the resources they need.
Primary Outcome
Prevalence estimates
Conditions Studied
Interventions
- OTHER No interventions
Study Locations (1)
Texas
- Corpus Christi Nueces County Health District - Corpus Christi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634 participants |
| Start Date | 2018-04-11 |
| Est. Completion | 2027-04-30 |
What the registry record for NCT03403257 still lists
NCT03403257 is an observational study that tracks outcomes without assigning an intervention. The registered 634 participants enrollment target is mid-sized for trials with a published cap, below the 7,720-participant average among 199 other Dementia trials with a reported enrollment target (92% lower).
The record links to 4 conditions, with Dementia appearing as the primary indexed condition, and to 1 intervention - of which No interventions is the first listed.
NCT03403257 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03403257 about?
NCT03403257 is a clinical study titled "Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)". The Mexican American population in the U.S. is rapidly growing and aging. This project seeks to determine the prevalence and outcomes of cognitive impairment and dementia in Mexican Americans. It also seeks solutions to help patients with cognitive impairment and dementia and their caregivers get th...
What is the current status of trial NCT03403257?
This trial is currently active not recruiting. The enrollment target is 634 participants. The study started on 2018-04-11. Estimated completion is 2027-04-30.
What conditions does trial NCT03403257 study?
This clinical trial studies the following conditions: Dementia, Dementia, Vascular, Dementia Alzheimers, Dementia, Mixed.
What interventions are being tested in trial NCT03403257?
The interventions under investigation include: No interventions (OTHER).
Who is sponsoring clinical trial NCT03403257?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03403257 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dementia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03403257's enrollment target sits among peer trials
634 41st of 199 higher than 159 of 199 other Dementia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dementia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
RECRUITING
-
Ferritin and Iron Burden in SAH sIRB
RECRUITING · Phase 1
-
δ in Dementia Clinical Trials
RECRUITING · NA
-
Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)
RECRUITING · Phase 1
-
Caregiver as Navigator: Develop Skills Online (CAN-DO)
RECRUITING · NA
-
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT07237295 · 634 participants · NA
CommunityRx-Kidney Health
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI